Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
Titel:
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
Auteur:
Younes, Anas Brody, Joshua Carpio, Cecilia Lopez-Guillermo, Armando Ben-Yehuda, Dina Ferhanoglu, Burhan Nagler, Arnon Ozcan, Muhit Avivi, Irit Bosch, Francesc Caballero Barrigón, Maria Dolores Hellmann, Andrzej Kuss, Bryone Ma, David D F Demirkan, Fatih Yağci, Münci Horowitz, Netanel A Marlton, Paula Cordoba, Raul Wrobel, Tomasz Buglio, Daniela Streit, Michael Hodkinson, Brendan P Schaffer, Michael Alvarez, John Ceulemans, Rob Balasubramanian, Sriram de Jong, Jan Wang, Shean-Sheng Fourneau, Nele Jurczak, Wojciech